Dr. Stephen C. Medlin, DO

Dr. Medlin practices at Aurora Sinai Medical Center - Mammography in Milwaukee, Wisconsin.

Dr. Medlin's NPI, 1134195159, was assigned on February 28, 2006. Dr. Medlin graduated from Des Moines University in 2001. Dr. Medlin holds Virginia license 0102207694.

Dr. Medlin's primary practice is Aurora Sinai Medical Center - Mammography, at 945 N 12th St, Milwaukee, WI 53233. The practice phone is (414) 219-7360.

Dr. Medlin's primary practice is Aurora Sinai Medical Center - Mammography in Milwaukee, Wisconsin. Dr. Medlin is also affiliated with Inova Fairfax Hospital. The medical group on file is Inova Urgent Care Center. Dmand AI also links Dr. Medlin to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Medlin practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Medlin's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Medlin is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Medlin's licenses on file in 4 states: Virginia, Ohio, South Dakota and Wisconsin.

Dmand AI lists circulatory problems in extremities, heart failure and immune deficiency disease among the conditions Dr. Medlin treats.

CMS data shows 229 Medicare services from Dr. Medlin across 3 procedure codes in 2023. Medicare paid $17,769 for them. Every service was in a facility, such as a hospital, rather than an office.

Across all payers, Dmand AI patient panel data puts Dr. Medlin's median patient age at 61, with 47% women.

In 2024, Dr. Medlin wrote 57 Medicare Part D claims for 20 patients. 84% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $141 in total drug cost. In 2023, CMS named 373 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Medlin for performance year 2024, reported as part of a group. Dr. Medlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Medlin, published from 2014 to 2024. 2024 was the busiest year, with 4. Dr. Medlin has published most often in J Patient Cent Res Rev. Dr. Medlin's most frequent co-authors are Zartash Gul, MD, Sherjeel Sana, MD and Michael J. Williams, MD.

Dmand AI links Dr. Medlin to 9 clinical trials, 5 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Lymphoma, Mantle-Cell, Lymphoma, Non-Hodgkin and Anemia, Aplastic. Medical College of Wisconsin sponsors the most, 2.

CMS Open Payments shows 65 general payments to Dr. Medlin from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. Kite Pharma, Inc. paid the most, $34,856.

Dmand AI lists 1 award for Dr. Medlin, most recently CMS Stage 1 EHR in 2012.

Dr. Medlin graduated from Des Moines University in 2001. Dr. Medlin is a member of ACP, ASCO and ASH.

Dr. Medlin is in network with 16 carriers, including United Healthcare, Cigna and Elevance. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.